Breakthrough antibody therapy targets Alzheimer’s risk gene, offers hope for effective treatment

Researchers introduced and characterized a novel platform based on monoclonal antibodies (mAbs).
Researchers introduced and characterized a novel platform based on monoclonal antibodies (mAbs).